Drägerwerk AG & Co. KGaA

  • WKN: 555060
  • ISIN: DE0005550602
  • Land: Deutschland

Nachricht vom 14.07.2020 | 19:08

Drägerwerk AG & Co. KGaA: preliminary result for the second quarter. Business development considerably above prior year.

Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results
Drägerwerk AG & Co. KGaA: preliminary result for the second quarter. Business development considerably above prior year.

14-Jul-2020 / 19:08 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


In the context of the COVID-19 pandemic, Dräger's net sales and EBIT development are considerably above the prior year.

Based on preliminary figures for the second quarter, Dräger recorded a year-on-year growth in order intake of 36.3 percent (net of currency effects; nominal: 33.6 percent). Net sales increased by 26.5 percent (net of currency effects; nominal: 24.3 percent) to around EUR 788.4 million (Q2 2019: EUR 634.3 million). EBIT for the second quarter stood at around EUR 102 million, considerably above the level of the prior year (Q2 2019: EUR -1.5 million). The higher earnings were caused by considerably higher net sales volume and a higher gross profit margin of around 49.2 percent (Q2 2019: 42.6 percent).

In the first six months of 2020, order intake increased by 75.7 percent year-on-year (net of currency effects; nominal: 73.5 percent). Due to the COVID-19 pandemic, demand in the medical division was exceptionally strong. In the safety division, demand for light breathing protection (e.g. FFP masks) was considerably above the prior year. Group net sales increased by 17.1 percent (net of currency effects; nominal: 15.6 percent) to around EUR 1,428.4 million (6 months 2019: EUR 1,235.9 million). Total EBIT stood at approximately EUR 102 million (6 months 2019: EUR -12.2 million).

Considering the high demand due to the COVID-19 pandemic, Dräger expects full year net sales and EBIT to be considerably above both the prior year and the original guidance. Dräger expects net sales growth for fiscal year 2020 to be between 14 percent and 22 percent (net of currency effects). The expectation for the EBIT margin is between 7.0 percent and 11.0 percent.

Dräger will publish its full results for the first six months of the fiscal year on August 13, 2020.
 

14-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

ESG-Whitepaper im Fokus

The Corporate ESG Guide: A 360 view on the current landscape and trends

Die ESG-Kriterien (Environmental, Social and Governance) werden auch für Emittenten immer wichtiger, wenn sie für Investoren attraktiv bleiben wollen. In dem Whitepaper “The Corporate ESG Guide: A 360 view on the current landscape and trends” beantworten die Experten von Investor Update grundlegende Fragen von Emittenten. Außerdem kommen Vermögensverwalter, Unternehmensberater Manager und ESG-Ratingagenturen zu wichtigen ESG-Themen zu Wort.

GBC-Fokusbox

"GBC Best of m:access 2020": Neue vielversprechende Auswahl

Unsere letztjährige „GBC Best of m:access“-Auswahl hat sich mit einer Performance von über 50 % überdurchschnittlich stark entwickelt und alle relevanten Indizes hinter sich gelassen. Im Rahmen der vorliegenden aktualisierten Studie präsentieren wir Ihnen eine in Teilen neu zusammengesetzte Selektion, die weiterhin 15 Unternehmen umfasst. Die aktuellen Einschätzungen zu den Einzeltiteln und auch weitere Informationen zur Entwicklung des m:access sind in der vollständigen Studie „GBC Best of m:access 2020“ enthalten.

News im Fokus

Vonovia SE: Als Dank für außergewöhnliche Leistung: Vonovia zahlt Belegschaft Corona-Prämie (News mit Zusatzmaterial)

24. November 2020, 15:17

Aktuelle Research-Studie

ABO Wind AG

Original-Research: ABO Wind AG (von First Berlin Equity Research GmbH): Buy

26. November 2020